As men age, a gradual decline in testosterone levels is a natural process. This decline, sometimes referred to as andropause or late-onset hypogonadism, can be associated with a variety of symptoms that impact quality of life, including decreased libido, reduced muscle mass and strength, increased body fat, and diminished energy levels. For older men experiencing these symptoms, testosterone replacement therapy (TRT) has emerged as a potential treatment. However, the decision to initiate TRT is complex and requires a careful consideration of the potential benefits and risks. The Testosterone Trials (TTrials), a landmark series of studies, provide valuable insights into the effects of TRT in men over 65.
What It Is
Testosterone is the primary male sex hormone, responsible for the development of male secondary sexual characteristics and the maintenance of reproductive tissues. It also plays a crucial role in bone density, muscle mass, and red blood cell production. In men, testosterone levels typically peak in early adulthood and then gradually decline with age. When testosterone levels fall below the normal range, and symptoms of hypogonadism are present, a diagnosis of late-onset hypogonadism may be made.
How It Works
TRT aims to restore testosterone levels to the normal physiological range, thereby alleviating the symptoms of hypogonadism. The therapy is available in various forms, including injections, gels, patches, and pellets. The choice of administration method depends on patient preference, cost, and the pharmacokinetic profile of the specific formulation. The goal of TRT is to mimic the natural diurnal rhythm of testosterone production, with higher levels in the morning and lower levels in the evening.
Key Research
The Testosterone Trials (TTrials) were a series of seven coordinated, randomized, placebo-controlled trials designed to assess the efficacy of TRT in older men with low testosterone levels. The main trial, published in the New England Journal of Medicine, found that TRT had a moderate benefit on sexual function, including sexual activity, desire, and erectile function Snyder PJ et al., 2016. The study also noted slight improvements in mood and depressive symptoms. However, there was no significant benefit in vitality or walking distance.
Subsequent analyses of the TTrials have provided further insights into the effects of TRT on specific health outcomes. The Bone Trial demonstrated that one year of testosterone treatment significantly increased volumetric bone mineral density and estimated bone strength in older men with low testosterone Snyder PJ et al., 2017. The Anemia Trial found that TRT was effective in correcting anemia in older men with low testosterone, both in cases of unexplained anemia and anemia from known causes Roy CN et al., 2017.
Benefits
The primary and most consistently reported benefit of TRT in older men is the improvement in sexual function. Research suggests that TRT can lead to significant improvements in libido, erectile function, and overall sexual satisfaction. Studies also indicate that TRT can have a positive impact on body composition, leading to an increase in lean muscle mass and a decrease in fat mass. Furthermore, the findings from the TTrials suggest that TRT can improve bone density and correct anemia, which are important considerations for the aging male population.
Risks & Side Effects
Despite the potential benefits, TRT is not without risks and side effects. One of the main concerns has been the potential for adverse cardiovascular events. The TRAVERSE trial, a large-scale study on the cardiovascular safety of testosterone therapy, found that TRT was noninferior to placebo with respect to the incidence of major adverse cardiac events in men with hypogonadism and preexisting or a high risk of cardiovascular disease Lincoff AM et al., 2023. However, the study did report a higher incidence of atrial fibrillation, acute kidney injury, and pulmonary embolism in the testosterone group. Other commonly observed side effects of TRT include acne, oily skin, and an increase in red blood cell count, which can increase the risk of blood clots. There is also a theoretical risk of stimulating the growth of prostate cancer, although long-term data are still needed to fully understand this risk Bhasin S et al., 2006.
Practical Considerations
Before starting TRT, a thorough medical evaluation is essential to confirm the diagnosis of hypogonadism and to rule out any contraindications. This evaluation should include a detailed medical history, physical examination, and at least two morning testosterone measurements. It is also important to discuss the potential benefits and risks of TRT with a healthcare provider and to have realistic expectations about the outcomes of treatment. Regular monitoring of testosterone levels, hematocrit, and prostate-specific antigen (PSA) is necessary during TRT to ensure safety and efficacy.
The Bottom Line
For older men with symptomatic late-onset hypogonadism, TRT can offer significant benefits, particularly in the realm of sexual function. The TTrials have provided valuable evidence supporting the use of TRT for improving bone density and correcting anemia in this population. However, the decision to initiate TRT should be made on an individual basis, after a comprehensive discussion of the potential benefits and risks with a qualified healthcare provider. The findings of the TRAVERSE trial provide some reassurance regarding cardiovascular safety, but the increased risk of certain adverse events highlights the importance of careful patient selection and monitoring.
This information is for educational purposes only. Always consult a licensed healthcare provider before starting any hormone therapy protocol.
